A 43-year-old member asked:
Cellcept (mycophenolate mofetil) for patients with antibody-negative myasthenia gravis; is it worth a trial?
1 doctor answer • 2 doctors weighed in
Dr. John Goldmananswered
Rheumatology 56 years experience
Yes: It is not clear exactly how the autoantibodies work. Antibody identification may not be 100 % and there may be other antibodies that have not been detected. Depending on what therapy has been tried CellCept (mycophenolate mofetil) may be appropriate. This is best discussed with your physician.
5.7k viewsReviewed >2 years ago
Last updated Jun 24, 2014
People also asked
Connect with a U.S. board-certified doctor by text or video anytime, anywhere.
24/7 visits - just $39!
50% off with $15/month membership
Disclaimer:
Content on HealthTap (including answers) should not be used for medical advice, diagnosis, or treatment, and interactions on HealthTap do not create a doctor-patient relationship. Never disregard or delay professional medical advice in person because of anything on HealthTap. Call your doctor or 911 if you think you may have a medical emergency.